{"disease":{"id":"cerebrovascular-occlusion","name":"Cerebrovascular Occlusion","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"apraclonidine","indication_name":"Cerebrovascular Occlusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iopidine","generic_name":"APRACLONIDINE","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"alpha-Adrenergic Agonist","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"ticlopidine","indication_name":"Cerebrovascular Occlusion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ticlid","generic_name":"TICLOPIDINE","company_name":"","drug_phase":"marketed","molecular_target":"P2Y12","drug_class":"ADP receptor antagonist","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04751708","title":"Endovascular Treatment for Acute Basilar Artery Occlusion","phase":"NA","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"The First Affiliated Hospital of University of Science and Technology of China","has_results":false},{"nct_id":"NCT05827042","title":"Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":338,"lead_sponsor_name":"The First Affiliated Hospital of University of Science and Technology of China","has_results":false},{"nct_id":"NCT05701956","title":"Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"The First Affiliated Hospital of University of Science and Technology of China","has_results":false},{"nct_id":"NCT07185022","title":"Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion","phase":"NA","overall_status":"RECRUITING","enrollment_count":282,"lead_sponsor_name":"The Second Hospital of Anhui Medical University","has_results":false},{"nct_id":"NCT06758609","title":"To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia Combined with Endovascular Reperfusion Therapy for Patients with Acute Anterior Circulation Large Artery Occlusion","phase":"NA","overall_status":"RECRUITING","enrollment_count":262,"lead_sponsor_name":"Guangdong Second Provincial General Hospital","has_results":false},{"nct_id":"NCT04985838","title":"Helping Ease Anxiety and Depression Following Stroke Stage 3","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Glasgow Caledonian University","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}